Synapse loss in dementias

Synaptic transmission is essential for nervous system function, and its dysfunction is a known major contributing factor to Alzheimer's‐type dementia. Antigen‐specific immunochemical methods are able to characterize synapse loss in dementia through the quantification of various synaptic protein...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuroscience research Vol. 88; no. 10; pp. 2083 - 2090
Main Authors Clare, Ryan, King, Victoria G., Wirenfeldt, Martin, Vinters, Harry V.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.08.2010
Subjects
Online AccessGet full text
ISSN0360-4012
1097-4547
1097-4547
DOI10.1002/jnr.22392

Cover

More Information
Summary:Synaptic transmission is essential for nervous system function, and its dysfunction is a known major contributing factor to Alzheimer's‐type dementia. Antigen‐specific immunochemical methods are able to characterize synapse loss in dementia through the quantification of various synaptic proteins involved in the synaptic cycle. These immunochemical methods applied to the study of Alzheimer's disease (AD) brain specimens have correlated synaptic loss with particularly toxic forms of amyloid‐β protein and have also established synapse loss as the best correlate of dementia severity. A significant but comparatively circumscribed amount of literature describes synaptic decline in other forms of dementia. Ischemic vascular dementia (IVD) is quite heterogeneous, and synapse loss in IVD seems to be variable among IVD subtypes, probably reflecting its variable neuropathologic correlates. Loss of synaptic protein has been identified in vascular dementia of the Binswanger type and Spatz‐Lindenberg's disease. Here we demonstrate a significant loss of synaptophysin density within the temporal lobe of frontotemporal dementia (FTD) patients. © 2010 Wiley‐Liss, Inc.
Bibliography:Turken Research Award
ArticleID:JNR22392
Daljit S. and Elaine Sarkaria Chair in Diagnostic Medicine
ark:/67375/WNG-BQRBKPLR-Q
istex:10764615EB154DA046C26DE6ABB6A81C152E8B86
Danish Agency for Science, Technology and Innovation
PHS - No. P50 AG16570; No. AG12435
The first two authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0360-4012
1097-4547
1097-4547
DOI:10.1002/jnr.22392